Lotus Eye Hospital And Institute Ltd · NSE:LOTUSEYE
Lotus Eye Hospital And Institute — Q3 FY2020-21 Earnings Presentation
23 slides from Lotus Eye Hospital And Institute's earnings presentation, Feb 9, 2021
Slide 1: Investor Presentation Q3 (FY 2020-2021)
Investor Presentation Q3 (FY 2020-2021)
Slide 2: Thanks to Our Founder
Thanks to OUR FOUNDER Late Dr. S. K. SUNDARAMOORTHY (21.08.1944 - 22.01.2020) “There are some who bring a light so great to the world that even after they have gone the light remains” Our founder Dr. S.K. Sundaramoorthy was one of the acclaimed and famed eye surgeons of our country and worldwide. He
Slide 3: Disclaimer
Disclaimer This presentation has been prepared by Lotus Eye Hospital and Institute Limited (the “Company”) solely for your information and for your use and may not be, distributed, reproduced, or redistributed or passed on, directly or indirectly, to any other person or published in whole or in part
Slide 4: Agenda
Agenda Overview Financial Performance Q3 Key Highlights Strategy going forward
Slide 5: Company Overview
Company Overview Founded in 1990 by renowned ophthalmic surgeon late Dr. S.K. Sundaramoorthy Lotus Eye Hospitals operates 7 Eye Care centers in Tamil Nadu and Kerala 5 Centres in Tamil Nadu: Coimbatore (Peelamedu & RS puram), Salem , Tirupur and Mettupalayam 2 Centres in Kerala: Kochi and Mu
Slide 6: Vision
Vision To become world’s leading eye care provider with happy and satisfied patients and stake holders. Lotus has a vision of "empowering eyes to illuminate lives". Lotus Eye Care group is marching towards its vision of becoming India's best Corporate Hospital with branches in strategic locations wh
Slide 7: Wide Range of Services
Wide Range of Services Refractive Ocuplasty Glaucoma TOUCH -FREE LASIK Enucleation Trabeculectomy SMILE Evisceration LASIK/ BladelessLASIK DCR &DCT Zyoptix & Zyoptix Ultimate PTOSIS Epizyoptix & Epizyoptix Ultimate Lateral Tarsorrhaphy SMILE Paediatric refraction and Specia
Slide 8: Key Milestones
Key Milestones 2002 1992 1994 (1) New center: Sitra, Inauguration of 1st company to introduce Coimbatore Lotus Eye Hospital Stitch-less Phaco- (2) Introduced Wave front and Research emulsification Cataract based Esiris Custom Lasik Centre surgery in Coimbatore for the 1st time in India 1 3 5 C1 Star
Slide 9: Key Milestones
Key Milestones 2005 Introduced Zyoptix Z100; 2008 2010 combined 2 technologies New center: (Epilasik and Zyoptix), known as Launch of IPO Mettupalayam Epizyoptix 8 10 12 C1 C2 7 9 11 (1) Inauguration of Hospital in Salem, Tamil Nadu, Inauguration Hospital Launched Intralase (2) 1st company in SEA to
Slide 10: Key Milestones
Key Milestones 2011 (1) New center: Kochi, 2019 Kerala, 2014 (2) Introduced Zyoptix Launched Schwind Supracor for the 1st Amaris 750Hz Touch New center: time in Tamil Nadu, Free Lasik Technology Mulanthuruthy, Kerala (3) Introduced Zyoptix at RS Puram Ultimate 217P technology 13 15 17 C2 14 16 Intro
Slide 11: Management
Management “In this aeon for LOTUS, the importance, emphasis and priority, will always be in ensuring and securing the credence and credibility of our existing shareholders.” Ms. Sangeetha Sundaramoorthy Managing Director “The ambition and objectives is to actualize and institute an earnest, unrelen
Slide 12: Sister Concern
SISTER CONCERN Lotus Vision Research Trust Vision Overview To prevent & eradicate blindness with dedication and • Established in 1993 humanitarian approach. • 200+Eye Camps conducted in single year • 120+ Free cataract surgery under DBCS Scheme • Runs Optometry Educational Institutions – 5000+ gradu
Slide 13: Agenda
Agenda Overview Financial Performance Q3 Key Highlights Strategy going forward
Slide 14: Financial Performance (for Quarter ending 31.12.2020)
Financial Performance (for Quarter ending 31.12.2020) REVENUE (3 MONTHS) (in lakhs) 31-12-20 30-09-20 31-12-19 Revenue from operations 987.34 717.3 1003.16 Other Income 19.96 21.98 24.54 Total Income 1007.29 839.28 1027.7 EXPENSES (3 MONTHS) (in lakhs) 31-12-20 30-09-20 31-12-19 Cost of Material Con
Slide 15: Financial Performance (for Quarter ending 31.12.2020)
Financial Performance (for Quarter ending 31.12.2020) REVENUE (9 MONTHS) (in lakhs) 31-12-20 31-12-19 Revenue from operations 2180.21 3238.47 Other Income 55.58 74.01 Total Income 2235.79 3312.48 EXPENSES (9 MONTHS) (in lakhs) 31-12-20 30-09-20 Cost of Material Consumed 338.75 482.51 Purchase of sto
Slide 16: Agenda
Agenda Overview Financial Performance Q3 Key Highlights Strategy going forward
Slide 17: Q3 Key Highlights
Q3 Key Highlights Mega Diabetic Eye Promotional TURN OUT THRESHOLD 5:1 RATIO Checkup in association with Thulasi Pharmacy & 31Lac CROSSED campaigns in Digital Media Audience Reach Rotary Clubs World Sight Day Dec’20 - All STUDENTS NEW 450+ TAKEN PART Drawing Competition in association with 5212 PATI
Slide 18: Q3 Key Highlights
Q3 Key Highlights Review Annual General Meeting Dr.SKS Bi-Weekly Doctor Knowledge Transfer Clinical Grand Rounds Sessions AGM Address by Chairman, MD & CEO VIEW Virtual Mode First Time Ever, all the Board Meetings & Annual General Meeting AGM was conducted through VC & OAVM Addressing Shareholder's
Slide 19: SWOT Analysis
SWOT Analysis INTERNAL STRENGTHS WEAKNESSES • Prominent Technology • Single Specialty • Leading Doctors • Presence only in South-India • Staunch and Robust Management • Steady Financials OPPORTUNITIES THREATS EXTERNAL • Opportunities in Adjacent Markets • Current Pandemic Situation • Medical technol
Slide 20: Agenda
Agenda Overview Financial Performance Q3 Key Highlights Strategy going forward
Slide 21: Strategy Going Forward
Strategy Going Forward >> Shaping workforce for the future Urgency towards digital resilience To build on existing strengths Output-outlay efficiency Limelight on centre excellence
Slide 22: Acumen of LOTUS
Lotus Eye Care Hospital is a hi-tech super specialty eye care hospital catering its value added service to the society since inception. Lotus is known for its excellence in Ophthalmic service Acumen of LOTUS C with personalized care. This organization is committedly hase pioneering in the technologi
Slide 23: Thanks!
Thanks! Any questions? You can reach us at: companysecretary@lotuseye.org
Lotus Eye Hospital and Institute — Q3 FY2020-21 Earnings Presentation on 6ix